These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 21221749)
1. Clinical and host genetic characteristics of Mendelian susceptibility to mycobacterial diseases in Japan. Hoshina T; Takada H; Sasaki-Mihara Y; Kusuhara K; Ohshima K; Okada S; Kobayashi M; Ohara O; Hara T J Clin Immunol; 2011 Jun; 31(3):309-14. PubMed ID: 21221749 [TBL] [Abstract][Full Text] [Related]
2. Mendelian Susceptibility to Mycobacterial Disease (MSMD): Clinical and Genetic Features of 32 Iranian Patients. Mahdaviani SA; Mansouri D; Jamee M; Zaki-Dizaji M; Aghdam KR; Mortaz E; Khorasanizadeh M; Eskian M; Movahedi M; Ghaffaripour H; Baghaie N; Hassanzad M; Chavoshzadeh Z; Mansouri M; Mesdaghi M; Ghaini M; Noori F; Eskandarzadeh S; Kahkooi S; Poorabdolah M; Tabarsi P; Moniri A; Farnia P; Karimi A; Boisson-Dupuis S; Rezaei N; Marjani M; Casanova JL; Bustamante J; Velayati AA J Clin Immunol; 2020 Aug; 40(6):872-882. PubMed ID: 32602053 [TBL] [Abstract][Full Text] [Related]
3. Severe disseminated mycobacterial infection in a boy with a novel mutation leading to IFN-γR2 deficiency. Kilic SS; van Wengen A; de Paus RA; Celebi S; Meziane B; Hafizoglu D; van Dissel JT; van de Vosse E J Infect; 2012 Dec; 65(6):568-72. PubMed ID: 22902943 [TBL] [Abstract][Full Text] [Related]
4. Current Status of the Management of Mendelian Susceptibility to Mycobacterial Disease in Mainland China. Ying W; Liu D; Dong X; Wang W; Hui X; Hou J; Yao H; Zhou Q; Sun B; Sun J; Wang X J Clin Immunol; 2019 Aug; 39(6):600-610. PubMed ID: 31367980 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of interleukin-12 receptor β1 and interferon gamma receptor 1 deficiency in patients with disseminated BCG infection. Pourakbari B; Hosseinpour Sadeghi R; Mahmoudi S; Parvaneh N; Keshavarz Valian S; Mamishi S Allergol Immunopathol (Madr); 2019; 47(1):38-42. PubMed ID: 30268380 [TBL] [Abstract][Full Text] [Related]
6. The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases. Al-Muhsen S; Casanova JL J Allergy Clin Immunol; 2008 Dec; 122(6):1043-51; quiz 1052-3. PubMed ID: 19084105 [TBL] [Abstract][Full Text] [Related]
7. Molecular immunity to mycobacteria: knowledge from the mutation and phenotype spectrum analysis of Mendelian susceptibility to mycobacterial diseases. Qu HQ; Fisher-Hoch SP; McCormick JB Int J Infect Dis; 2011 May; 15(5):e305-13. PubMed ID: 21330176 [TBL] [Abstract][Full Text] [Related]
8. Clinical and immunological profile of children with Mendelian Susceptibility to Mycobacterial Diseases (MSMD) from an Indian tertiary care hospital. Indumathi CK; Bustamante J Indian J Tuberc; 2021 Apr; 68(2):292-297. PubMed ID: 33845970 [TBL] [Abstract][Full Text] [Related]
12. Haploinsufficiency at the human IFNGR2 locus contributes to mycobacterial disease. Kong XF; Vogt G; Itan Y; Macura-Biegun A; Szaflarska A; Kowalczyk D; Chapgier A; Abhyankar A; Furthner D; Djambas Khayat C; Okada S; Bryant VL; Bogunovic D; Kreins A; Moncada-Vélez M; Migaud M; Al-Ajaji S; Al-Muhsen S; Holland SM; Abel L; Picard C; Chaussabel D; Bustamante J; Casanova JL; Boisson-Dupuis S Hum Mol Genet; 2013 Feb; 22(4):769-81. PubMed ID: 23161749 [TBL] [Abstract][Full Text] [Related]
13. Clinical and Molecular Findings in Mendelian Susceptibility to Mycobacterial Diseases: Experience From India. Taur PD; Gowri V; Pandrowala AA; Iyengar VV; Chougule A; Golwala Z; Chandak S; Agarwal R; Keni P; Dighe N; Bodhanwala M; Prabhu S; George B; Fouzia NA; Edison ES; Arunachalam AK; Madkaikar MR; Dalvi AD; Yadav RM; Bargir UA; Kambli PM; Rawat A; Das J; Joshi V; Pilania RK; Jindal AK; Bhat S; Bhattad S; Unni J; Radhakrishnan N; Raj R; Uppuluri R; Patel S; Lashkari HP; Aggarwal A; Kalra M; Udwadia Z; Bafna VS; Kanade T; Puel A; Bustamante J; Casanova JL; Desai MM Front Immunol; 2021; 12():631298. PubMed ID: 33732252 [TBL] [Abstract][Full Text] [Related]
14. Enhanced osteoclastogenesis in patients with MSMD due to impaired response to IFN-γ. Tsumura M; Miki M; Mizoguchi Y; Hirata O; Nishimura S; Tamaura M; Kagawa R; Hayakawa S; Kobayashi M; Okada S J Allergy Clin Immunol; 2022 Jan; 149(1):252-261.e6. PubMed ID: 34176646 [TBL] [Abstract][Full Text] [Related]
15. X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. Filipe-Santos O; Bustamante J; Haverkamp MH; Vinolo E; Ku CL; Puel A; Frucht DM; Christel K; von Bernuth H; Jouanguy E; Feinberg J; Durandy A; Senechal B; Chapgier A; Vogt G; de Beaucoudrey L; Fieschi C; Picard C; Garfa M; Chemli J; Bejaoui M; Tsolia MN; Kutukculer N; Plebani A; Notarangelo L; Bodemer C; Geissmann F; Israël A; Véron M; Knackstedt M; Barbouche R; Abel L; Magdorf K; Gendrel D; Agou F; Holland SM; Casanova JL J Exp Med; 2006 Jul; 203(7):1745-59. PubMed ID: 16818673 [TBL] [Abstract][Full Text] [Related]
16. Three novel compound heterozygous IL12RB1 mutations in Chinese patients with Mendelian susceptibility to mycobacterial disease. Zhou X; Jia W; Ni Z; Wang A; Liu Z; Hou M; Zhou M; Tang Z; Zhang D; Li L; Han T; Tan Y; Luo G; Wang J; Wu Y; Zhang X PLoS One; 2019; 14(4):e0215648. PubMed ID: 30998751 [TBL] [Abstract][Full Text] [Related]